Two young rebellious scientists are told by their employers to halt groundbreaking work that has seen them produce new creatures with medical benefits by splicing together multiple organisms' DNA.

Vernacare International, a portfolio business of H.I.G. Capital, has snapped up a designer and manufacturer of specialist medical and technical devices, in a deal supported by Castle Corporate Finance ...